{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:07:16Z","timestamp":1786982836820,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s40618-018-0901-5","type":"journal-article","created":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T10:15:47Z","timestamp":1527848147000},"page":"129-135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Advances and controversies in the classification and grading of pituitary tumors"],"prefix":"10.1007","volume":"42","author":[{"suffix":"Jr.","given":"E. R.","family":"Laws","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. L.","family":"Penn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. S.","family":"Repetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,1]]},"reference":[{"issue":"3","key":"901_CR1","doi-asserted-by":"publisher","first-page":"527","DOI":"10.3171\/2014.5.jns131819","volume":"121","author":"H Gittleman","year":"2014","unstructured":"Gittleman H, Ostrom QT, Farah PD, Ondracek A, Chen Y, Wolinsky Y, Kruchko C, Singer J, Kshettry VR, Laws ER, Sloan AE, Selman WR, Barnholtz-Sloan JS (2014) Descriptive epidemiology of pituitary tumors in the United States, 2004\u20132009. J Neurosurg 121(3):527\u2013535. \n                    https:\/\/doi.org\/10.3171\/2014.5.jns131819","journal-title":"J Neurosurg"},{"issue":"Suppl 2","key":"901_CR2","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1093\/neuonc\/not151","volume":"15","author":"QT Ostrom","year":"2013","unstructured":"Ostrom QT, Gittleman H, Farah P, Ondracek A, Chen Y, Wolinsky Y, Stroup NE, Kruchko C, Barnholtz-Sloan JS (2013) CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006\u20132010. Neurooncology 15(Suppl 2):ii1\u2013ii56. \n                    https:\/\/doi.org\/10.1093\/neuonc\/not151","journal-title":"Neurooncology"},{"key":"901_CR3","first-page":"537","volume":"27","author":"C Benda","year":"1901","unstructured":"Benda C (1901) Die mikroscopische Befunde bei vier Fallen von Akromegalie. Dtsch Med Wochenschr 27:537\u2013539","journal-title":"Dtsch Med Wochenschr"},{"key":"901_CR4","first-page":"158","volume":"33","author":"J Erdheim","year":"1903","unstructured":"Erdheim J (1903) Zur normalen und pathologischen Histologie der Glandula thyreoidea, parathyroidea und Hypophysis. Beitr pathol Anat 33:158\u2013236","journal-title":"Beitr pathol Anat"},{"key":"901_CR5","first-page":"44","volume":"188","author":"C Loewenstein","year":"1907","unstructured":"Loewenstein C (1907) Die Entwicklung der Hypophysisadenome. Ein Beitr Lehre Geschw\u00fclsten 188:44\u201365","journal-title":"Ein Beitr Lehre Geschw\u00fclsten"},{"issue":"3","key":"901_CR6","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/(sici)1097-0142(19960801)78:3<502::aid-cncr18>3.0.co;2-2","volume":"78","author":"K Kovacs","year":"1996","unstructured":"Kovacs K, Scheithauer BW, Horvath E, Lloyd RV (1996) The World Health Organization classification of adenohypophysial neoplasms. A proposed five-tier scheme. Cancer 78(3):502\u2013510. https:\/\/doi.org\/10.1002\/(sici)1097-0142(19960801)78:3<502:aid-cncr18>3.0.co;2-2","journal-title":"Cancer"},{"key":"901_CR7","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/00019616-199301000-00007","volume":"3","author":"K Thapar","year":"1993","unstructured":"Thapar K, Kovacs K, Laws ER, Muller PJ (1993) Pituitary adenomas: current concepts in classification, histopathology, and molecular biology. Endocrinologist 3:39\u201357","journal-title":"Endocrinologist"},{"key":"901_CR8","first-page":"27","volume-title":"Pituitary adenomas","author":"J Trouillas","year":"1996","unstructured":"Trouillas J, Girod C (1996) Pathology of pituitary adenomas. In: Landolt AM, Vance M, Reilly PL (eds) Pituitary adenomas. Churchill Livingstone, New York, pp 27\u201346"},{"issue":"6","key":"901_CR9","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.1210\/jcem.81.6.8964846","volume":"81","author":"SL Asa","year":"1996","unstructured":"Asa SL, Bamberger AM, Cao B, Wong M, Parker KL, Ezzat S (1996) The transcription activator steroidogenic factor-1 is preferentially expressed in the human pituitary gonadotroph. J Clin Endocrinol Metab 81(6):2165\u20132170. \n                    https:\/\/doi.org\/10.1210\/jcem.81.6.8964846","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"901_CR10","doi-asserted-by":"publisher","first-page":"C5","DOI":"10.1530\/erc-17-0004","volume":"24","author":"SL Asa","year":"2017","unstructured":"Asa SL, Casar-Borota O, Chanson P, Delgrange E, Earls P, Ezzat S, Grossman A, Ikeda H, Inoshita N, Karavitaki N, Korbonits M, Laws ER Jr, Lopes MB, Maartens N, McCutcheon IE, Mete O, Nishioka H, Raverot G, Roncaroli F, Saeger W, Syro LV, Vasiljevic A, Villa C, Wierinckx A, Trouillas J, and the Attendees of 14th Meeting of the International Pituitary Pathology Club AFN (2017) From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. Endocr Relat Cancer 24(4):C5\u2013C8. \n                    https:\/\/doi.org\/10.1530\/erc-17-0004","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"901_CR11","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1210\/jcem.77.5.8077322","volume":"77","author":"KE Friend","year":"1993","unstructured":"Friend KE, Chiou YK, Laws ER Jr, Lopes MB, Shupnik MA (1993) Pit-1 messenger ribonucleic acid is differentially expressed in human pituitary adenomas. J Clin Endocrinol Metab 77(5):1281\u20131286. \n                    https:\/\/doi.org\/10.1210\/jcem.77.5.8077322","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"901_CR12","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/(sici)1097-0029(19971015)39:2<168::aid-jemt8>3.0.co;2-h","volume":"39","author":"RV Lloyd","year":"1997","unstructured":"Lloyd RV, Osamura RY (1997) Transcription factors in normal and neoplastic pituitary tissues. Microsc Res Tech 39(2):168\u2013181. https:\/\/doi.org\/10.1002\/(sici)1097-0029(19971015)39:2<168:aid-jemt8>3.0.co;2-h","journal-title":"Microsc Res Tech"},{"issue":"34","key":"901_CR13","doi-asserted-by":"publisher","first-page":"8932","DOI":"10.1021\/bi00085a026","volume":"32","author":"ME Mason","year":"1993","unstructured":"Mason ME, Friend KE, Copper J, Shupnik MA (1993) Pit-1\/GHF-1 binds to TRH-sensitive regions of the rat thyrotropin beta gene. Biochemistry 32(34):8932\u20138938","journal-title":"Biochemistry"},{"issue":"2","key":"901_CR14","doi-asserted-by":"publisher","first-page":"E17","DOI":"10.3171\/2014.10.focus14683","volume":"38","author":"J Seltzer","year":"2015","unstructured":"Seltzer J, Ashton CE, Scotton TC, Pangal D, Carmichael JD, Zada G (2015) Gene and protein expression in pituitary corticotroph adenomas: a systematic review of the literature. Neurosurg Focus 38(2):E17. \n                    https:\/\/doi.org\/10.3171\/2014.10.focus14683","journal-title":"Neurosurg Focus"},{"key":"901_CR15","unstructured":"WHO Classification of tumours of endocrine organs (2017), vol 10, 4th edn. IARC Publications, Lyon"},{"issue":"4","key":"901_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s00401-017-1769-8","volume":"134","author":"MBS Lopes","year":"2017","unstructured":"Lopes MBS (2017) The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134(4):521\u2013535. \n                    https:\/\/doi.org\/10.1007\/s00401-017-1769-8","journal-title":"Acta Neuropathol"},{"issue":"3","key":"901_CR17","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1007\/s12022-017-9498-z","volume":"28","author":"O Mete","year":"2017","unstructured":"Mete O, Lopes MB (2017) Overview of the 2017 WHO classification of pituitary tumors. Endocr Pathol 28(3):228\u2013243. \n                    https:\/\/doi.org\/10.1007\/s12022-017-9498-z","journal-title":"Endocr Pathol"},{"key":"901_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s10014-018-0311-6","author":"M Shibuya","year":"2018","unstructured":"Shibuya M (2018) Welcoming the new WHO classification of pituitary tumors 2017: revolution in TTF-1-positive posterior pituitary tumors. Brain Tumor Pathol. \n                    https:\/\/doi.org\/10.1007\/s10014-018-0311-6","journal-title":"Brain Tumor Pathol"},{"issue":"6","key":"901_CR19","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1227\/neu.0000000000001188","volume":"79","author":"DJ Cote","year":"2016","unstructured":"Cote DJ, Smith TR, Sandler CN, Gupta T, Bale TA, Bi WL, Dunn IF, De Girolami U, Woodmansee WW, Kaiser UB, Laws ER Jr (2016) Functional gonadotroph adenomas: case series and report of literature. Neurosurgery 79(6):823\u2013831. \n                    https:\/\/doi.org\/10.1227\/neu.0000000000001188","journal-title":"Neurosurgery"},{"issue":"1","key":"901_CR20","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s12022-014-9347-2","volume":"26","author":"JA Balogun","year":"2015","unstructured":"Balogun JA, Monsalves E, Juraschka K, Parvez K, Kucharczyk W, Mete O, Gentili F, Zadeh G (2015) Null cell adenomas of the pituitary gland: an institutional review of their clinical imaging and behavioral characteristics. Endocr Pathol 26(1):63\u201370. \n                    https:\/\/doi.org\/10.1007\/s12022-014-9347-2","journal-title":"Endocr Pathol"},{"issue":"1","key":"901_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ecl.2014.10.001","volume":"44","author":"G Raverot","year":"2015","unstructured":"Raverot G, Vasiljevic A, Jouanneau E, Trouillas J (2015) A prognostic clinicopathologic classification of pituitary endocrine tumors. Endocrinol Metab Clin N Am 44(1):11\u201318. \n                    https:\/\/doi.org\/10.1016\/j.ecl.2014.10.001","journal-title":"Endocrinol Metab Clin N Am"},{"issue":"1","key":"901_CR22","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","volume":"126","author":"J Trouillas","year":"2013","unstructured":"Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, Viennet G, Bonneville JF, Assaker R, Auger C, Brue T, Cornelius A, Dufour H, Jouanneau E, Francois P, Galland F, Mougel F, Chapuis F, Villeneuve L, Maurage CA, Figarella-Branger D, Raverot G, Members of H, Barlier A, Bernier M, Bonnet F, Borson-Chazot F, Brassier G, Caulet-Maugendre S, Chabre O, Chanson P, Cottier JF, Delemer B, Delgrange E, Di Tommaso L, Eimer S, Gaillard S, Jan M, Girard JJ, Lapras V, Loiseau H, Passagia JG, Patey M, Penfornis A, Poirier JY, Perrin G, Tabarin A (2013) A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case\u2013control study of 410 patients with 8\u00a0years post-operative follow-up. Acta Neuropathol 126(1):123\u2013135. \n                    https:\/\/doi.org\/10.1007\/s00401-013-1084-y","journal-title":"Acta Neuropathol"},{"key":"901_CR23","doi-asserted-by":"crossref","unstructured":"Thapar K, Kovacs K, Laws E (1995) The classification and molecular biology of pituitary adenomas. In: Advances and technical standards in neurosurgery. Springer, Wien, p 3\u201353","DOI":"10.1007\/978-3-7091-6898-1_1"},{"key":"901_CR24","unstructured":"Thapar K, Scheithauer BW, Kovacs K, Pernicone PJ, Laws Jr ER (1996) p53 expression in pituitary adenomas and carcinomas: correlation with invasiveness and tumor growth fractions. Neurosurgery 38(4):765\u2013770; discussion 770\u2013761"},{"issue":"2","key":"901_CR25","doi-asserted-by":"publisher","first-page":"336","DOI":"10.3171\/2010.8.jns10290","volume":"114","author":"G Zada","year":"2011","unstructured":"Zada G, Woodmansee WW, Ramkissoon S, Amadio J, Nose V, Laws ER Jr (2011) Atypical pituitary adenomas: incidence, clinical characteristics, and implications. J Neurosurg 114(2):336\u2013344. \n                    https:\/\/doi.org\/10.3171\/2010.8.jns10290","journal-title":"J Neurosurg"},{"issue":"3","key":"901_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3171\/jns.1986.64.3.0402","volume":"64","author":"WR Selman","year":"1986","unstructured":"Selman WR, Laws ER, Scheithauer BW, Carpenter SM (1986) The occurrence of dural invasion in pituitary adenomas. J Neurosurg 64(3):402\u2013407","journal-title":"J Neurosurg"},{"key":"901_CR27","doi-asserted-by":"crossref","unstructured":"Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D, Laws Jr ER (1996) Proliferative activity and invasiveness among pituitary adenomas and carcinomas: an analysis using the MIB-1 antibody. Neurosurgery 38(1):99\u2013106; discussion 106\u2013107","DOI":"10.1097\/00006123-199601000-00024"},{"issue":"6","key":"901_CR28","doi-asserted-by":"publisher","first-page":"733","DOI":"10.3171\/jns.1986.65.6.0733","volume":"65","author":"BW Scheithauer","year":"1986","unstructured":"Scheithauer BW, Kovacs KT, Laws ER Jr, Randall RV (1986) Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65(6):733\u2013744. \n                    https:\/\/doi.org\/10.3171\/jns.1986.65.6.0733","journal-title":"J Neurosurg"},{"issue":"2","key":"901_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3171\/jns.2002.96.2.0195","volume":"96","author":"BP Meij","year":"2002","unstructured":"Meij BP, Lopes MB, Ellegala DB, Alden TD, Laws ER Jr (2002) The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery. J Neurosurg 96(2):195\u2013208. \n                    https:\/\/doi.org\/10.3171\/jns.2002.96.2.0195","journal-title":"J Neurosurg"},{"issue":"4","key":"901_CR30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1136\/jmedgenet-2017-104957","volume":"55","author":"F Caimari","year":"2018","unstructured":"Caimari F, Hernandez-Ramirez LC, Dang MN, Gabrovska P, Iacovazzo D, Stals K, Ellard S, Korbonits M, International Fc (2018) Risk category system to identify pituitary adenoma patients with AIP mutations. J Med Genet 55(4):254\u2013260. \n                    https:\/\/doi.org\/10.1136\/jmedgenet-2017-104957","journal-title":"J Med Genet"},{"issue":"11","key":"901_CR31","doi-asserted-by":"publisher","first-page":"E373","DOI":"10.1210\/jc.2009-2556","volume":"95","author":"AF Daly","year":"2010","unstructured":"Daly AF, Tichomirowa MA, Petrossians P, Heliovaara E, Jaffrain-Rea ML, Barlier A, Naves LA, Ebeling T, Karhu A, Raappana A, Cazabat L, De Menis E, Montanana CF, Raverot G, Weil RJ, Sane T, Maiter D, Neggers S, Yaneva M, Tabarin A, Verrua E, Eloranta E, Murat A, Vierimaa O, Salmela PI, Emy P, Toledo RA, Sabate MI, Villa C, Popelier M, Salvatori R, Jennings J, Longas AF, Labarta Aizpun JI, Georgitsi M, Paschke R, Ronchi C, Valimaki M, Saloranta C, De Herder W, Cozzi R, Guitelman M, Magri F, Lagonigro MS, Halaby G, Corman V, Hagelstein MT, Vanbellinghen JF, Barra GB, Gimenez-Roqueplo AP, Cameron FJ, Borson-Chazot F, Holdaway I, Toledo SP, Stalla GK, Spada A, Zacharieva S, Bertherat J, Brue T, Bours V, Chanson P, Aaltonen LA, Beckers A (2010) Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J Clin Endocrinol Metab 95(11):E373\u2013E383. \n                    https:\/\/doi.org\/10.1210\/jc.2009-2556","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"901_CR32","doi-asserted-by":"publisher","first-page":"L25","DOI":"10.1530\/erc-12-0020","volume":"19","author":"L Kasuki","year":"2012","unstructured":"Kasuki L, Vieira Neto L, Wildemberg LE, Colli LM, de Castro M, Takiya CM, Gadelha MR (2012) AIP expression in sporadic somatotropinomas is a predictor of the response to octreotide LAR therapy independent of SSTR2 expression. Endocr Relat Cancer 19(3):L25\u2013L29. \n                    https:\/\/doi.org\/10.1530\/erc-12-0020","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"901_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1530\/eje-12-0457","volume":"168","author":"J Oriola","year":"2013","unstructured":"Oriola J, Lucas T, Halperin I, Mora M, Perales MJ, Alvarez-Escola C, de Paz MN, Diaz Soto G, Salinas I, Julian MT, Olaizola I, Bernabeu I, Marazuela M, Puig-Domingo M (2013) Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues. Eur J Endocrinol 168(1):9\u201313. \n                    https:\/\/doi.org\/10.1530\/eje-12-0457","journal-title":"Eur J Endocrinol"},{"key":"901_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.jocn.2016.09.014","volume":"34","author":"HA Zaidi","year":"2016","unstructured":"Zaidi HA, Cote DJ, Dunn IF, Laws ER Jr (2016) Predictors of aggressive clinical phenotype among immunohistochemically confirmed atypical adenomas. J Clin Neurosci 34:246\u2013251. \n                    https:\/\/doi.org\/10.1016\/j.jocn.2016.09.014","journal-title":"J Clin Neurosci"},{"issue":"9","key":"901_CR35","doi-asserted-by":"publisher","first-page":"3368","DOI":"10.1210\/jc.2017-00773","volume":"102","author":"G Raverot","year":"2017","unstructured":"Raverot G, Dantony E, Beauvy J, Vasiljevic A, Mikolasek S, Borson-Chazot F, Jouanneau E, Roy P, Trouillas J (2017) Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification. J Clin Endocrinol Metab 102(9):3368\u20133374. \n                    https:\/\/doi.org\/10.1210\/jc.2017-00773","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"901_CR36","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/eje-17-0796","volume":"178","author":"G Raverot","year":"2018","unstructured":"Raverot G, Burman P, McCormack A, Heaney A, Petersenn S, Popovic V, Trouillas J, Dekkers OM, European Society of E (2018) European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol 178(1):G1\u2013G24. \n                    https:\/\/doi.org\/10.1530\/eje-17-0796","journal-title":"Eur J Endocrinol"},{"issue":"9","key":"901_CR37","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1210\/jc.2017-00792","volume":"102","author":"KA Oystese","year":"2017","unstructured":"Oystese KA, Casar-Borota O, Normann KR, Zucknick M, Berg JP, Bollerslev J (2017) Estrogen receptor alpha, a sex-dependent predictor of aggressiveness in nonfunctioning pituitary adenomas: SSTR and sex hormone receptor distribution in NFPA. J Clin Endocrinol Metab 102(9):3581\u20133590. \n                    https:\/\/doi.org\/10.1210\/jc.2017-00792","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"901_CR38","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40618-015-0353-0","volume":"39","author":"LG Perez-Rivas","year":"2016","unstructured":"Perez-Rivas LG, Reincke M (2016) Genetics of Cushing\u2019s disease: an update. J Endocrinol Investig 39(1):29\u201335. \n                    https:\/\/doi.org\/10.1007\/s40618-015-0353-0","journal-title":"J Endocrinol Investig"},{"issue":"1","key":"901_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1385\/endo:28:1:115","volume":"28","author":"MB Lopes","year":"2005","unstructured":"Lopes MB, Scheithauer BW, Schiff D (2005) Pituitary carcinoma: diagnosis and treatment. Endocrine 28(1):115\u2013121. \n                    https:\/\/doi.org\/10.1385\/endo:28:1:115","journal-title":"Endocrine"},{"issue":"2","key":"901_CR40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1227\/01.NEU.0000223437.51435.6E","volume":"59","author":"BW Scheithauer","year":"2006","unstructured":"Scheithauer BW, Gaffey TA, Lloyd RV, Sebo TJ, Kovacs KT, Horvath E, Yap\u0131c\u0131er \u00d6, Young WF, Meyer FB, Kuroki T, Riehle DL (2006) Pathobiology of pituitary adenomas and carcinomas. Neurosurgery 59(2):341\u2013353","journal-title":"Neurosurgery"},{"issue":"3","key":"901_CR41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.14310\/horm.2002.1195","volume":"2","author":"M Al-Gahtany","year":"2003","unstructured":"Al-Gahtany M, Horvath E, Kovacs K (2003) Pituitary hyperplasia. Hormones 2(3):149\u2013158","journal-title":"Hormones"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40618-018-0901-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0901-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-018-0901-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T14:05:54Z","timestamp":1581948354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40618-018-0901-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,1]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["901"],"URL":"https:\/\/doi.org\/10.1007\/s40618-018-0901-5","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,1]]},"assertion":[{"value":"18 April 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest. The authors declare that they have no conflict of interest, either financial or non-financial.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"There is no identifying patient information present in this manuscript; therefore, informed consent is unnecessary.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}